Propiedad y actividad de insiders de Nurix Therapeutics, Inc. (NRIX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $24.83 |
| Capitalización | $2.6B |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $25.6M | $34.8M | $119.4M | $80.5M | $64.5M | $54.6M | $110.0M | $247.0M |
| Inversiones a Corto | $13.4M | $2.9M | $161.8M | $215.2M | $244.7M | $233.3M | $499.6M | $346.0M |
| Cuentas por Cobrar | 0 | 0 | $11.3M | $6.2M | $1.1M | $800000 | $1.5M | 0 |
| Inventario | 0 | 0 | 0 | 0 | -$1.1M | 0 | 0 | 0 |
| Activos Corrientes | $40.7M | $39.4M | $298.4M | $311.1M | $318.4M | $295.5M | $619.4M | $606.8M |
| Inmovilizado Material | $4.4M | $3.9M | $6.7M | $25.3M | $29.5M | $48.0M | $45.9M | $73.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $45.4M | $44.0M | $396.3M | $476.8M | $416.8M | $355.6M | $669.3M | $688.1M |
| Cuentas por Pagar | $1.3M | $1.6M | $3.4M | $6.7M | $5.1M | $6.4M | $11.5M | $11.2M |
| Deuda a Corto | 0 | 0 | 0 | $3.8M | $5.5M | $7.5M | 0 | 0 |
| Pasivos Corrientes | $32.8M | $16.1M | $44.5M | $66.3M | $70.7M | $87.0M | $95.9M | $86.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $34.0M | $53.6M | $106.1M | $134.5M | $113.1M | $155.1M | $142.3M | $149.4M |
| Reservas | -$38.8M | -$60.5M | -$103.7M | -$220.9M | -$401.3M | -$545.2M | -$738.8M | -$1.00B |
| Patrimonio Neto | -$36.8M | -$57.7M | $290.3M | $342.3M | $303.7M | $200.5M | $527.0M | $538.7M |
| Deuda Total | 0 | 0 | 0 | $13.0M | $12.0M | $30.6M | $28.3M | $55.7M |
| Deuda Neta | -$39.0M | -$37.7M | -$281.1M | -$282.7M | -$297.2M | -$257.3M | -$581.3M | -$537.2M |
| Capital Circulante | $7.8M | $23.2M | $253.9M | $244.9M | $247.8M | $208.5M | $523.5M | $520.3M |
Salud financiera
| Deuda / Patrimonio | 0.14 |
| Ratio corriente | 6.34 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 3.50 |
Rentabilidad
| Rentabilidad sobre capital | -76.09% |
| Rentabilidad sobre capital invertido | -77.32% |
| Rentabilidad sobre activos | -63.74% |
| Margen bruto | -165.51% |
| Margen operativo | -982.37% |
| Margen neto | -928.44% |
Empresas relacionadas: BBOT · EYPT · FTRE · KOD · KURA · PHAT · SEPN
Explorar sector: Healthcare · Biotechnology
Más secciones de NRIX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones